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Highlights 
1. The cogrinding process produced polymorphic transformations in CBZ 
2. GLU exhibited lower charge densities as compared to CBZ 
3. Net charge density decreases with increasing CBZ content up to 30 % above which net 
charge density increases 
4. Technique could be used to determine appropriate formulations that improve handling 
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Abstract 
One of strategies adopted to improve the dissolution rates of poorly soluble drugs is by co-grinding 
the drug with a hydrophilic carrier. However, the introduction of mechanical forces during the 
grinding process can lead to changes in the physicochemical characteristics as well as an increase in 
the surface free energy of the ground particles, which causes an alteration in the electrostatic 
properties of these particles. The solid state characteristics of glucosamine hydrochloride (GLU) 
and carbamazepine (CBZ) and their co-ground mixtures were studied using DSC, XRPD and SEM. 
These revealed that polymorphic transformations occurred due to the grinding process. The 
influence of grinding time on the triboelectrification properties of the formulations was also studied. 
Both pure CBZ and GLU powders were predominantly electro-positively charged and their 
charging properties increased with increasing grinding time. CBZ:GLU physical mixtures exhibited 
complicated bipolar charging behaviour,  however, when subjected to grinding, these mixtures 
demonstrated mainly electronegative charge properties. The influence of both grinding time and 
CBZ content within CBZ:GLU mixtures were examined. The value of net-electronegative-charge 
density of CBZ:GLU mixtures was shown to increase with grinding time and /or when increasing 
the percentage proportion of CBZ up to 30 % w:w. This study helps to provide information about 
the handling of these formulation and gives a formulator tools to ascertain appropriate ratios for 
handling and possible simultaneous dissolution improvements.  
 
Keywords: Electrostatics; Solid dispersions; Triboelectrification; Carbamazepine; D-glucosamine 
HCl; Polymorphism. 
Abbreviations: GLU, glucosamine hydrochloride; DSC, differential scanning calorimetry; XRPD, 
x-ray powder diffraction; BCS, biopharmaceutical classification system; CBZ, carbamazepine; 
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SEM, scanning electron microscopy; RH, relative humidity; PSD, particle size distribution; PM, 
physical mixture. 
1. Introduction 
The poor aqueous solubility of BCS Class II drugs and new chemical entities is a major problem 
being faced in pharmaceutical development. The solubility and dissolution rate of these drugs are 
important determinants of the rate and extent of their absorption from the gastrointestinal tract. In 
addition, for this class of drugs, dissolution rates are the rate limiting step for bioavailability, 
therefore enhancing the dissolution rate is crucial to achieving therapeutic blood concentrations.  
Several techniques have been explored to enhance the dissolution rate of poorly soluble drugs and 
they include particle size reduction [1], solid dispersion formation [2], complexation [3] and salt 
formation [4]. The particle size reduction method has been extensively used in attempts to improve 
dissolution rate of poorly soluble drugs [5, 6] because the reduction in particle size and the 
subsequent increase in surface area can enhance the dissolution rate and consequently the 
bioavailability of these pharmaceutical materials. This method is promising but still has some 
difficulties in its application. 
Size reduction of pharmaceutical materials is often performed by a dry milling process, requiring a 
high energy input, and it has been reported that the strong mechanical forces required (such as 
grinding) may increase the surface free energy and cause distortion of the crystal lattice as well as 
reduce particle size [7]. In addition, grinding of hydrophobic drugs usually causes aggregation of 
drug particles, therefore size reduction by dry milling is limited to around 3 µm due to aggregation 
between particles at sub-micron diameters [8]. These aggregates have a reduced effective surface 
area available for dissolution. Size reduction in the nanometer range must be carried out by other 
techniques such as salt-assisted milling [9]. Recent research has explored particle size reduction to 
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the submicron range by co-grinding with additives [10 - 13].  Co-grinding is economically and 
environmentally desirable as, unlike other techniques, it does not require toxic solvents [14] and 
sophisticated equipment [15].   
Pharmaceutical powders usually have insulating properties with relatively small particle size and 
low bulk density and as such they are susceptible to triboelectric charging, especially during 
mechanical processing when particles collide with walls of containers and with each other [16, 17].. 
In addition, particle charging can cause problems in the manufacture of formulations by affecting 
powder flow, reducing fill and dose uniformity [18, 19]; for example particle charging may cause 
adhesion and deposition of particles to walls especially in case of fine particles such as in dry 
powder inhalers [20, 21]. Triboelectrification has been used to study the impact of the counter ion 
on flurbiprofen salts as a consideration during the preformulation process [22], reduce the charging 
of flurbiprofen (a drug with a high propensity for charging) in binary mixtures of cellulose ethers 
[23], ordered mixing [24] and recently as a way of manipulating the charge of their final product of 
solid dispersions using single solvents and binary mixtures of solvents [25].  
Al-Hamidi et al., [2] explored the use of D-glucosamine HCl (GLU) as a potential excipient to 
improve the dissolution rate of poorly soluble drug by use of the co-grinding approach. They also 
investigated the effect of the order of grinding on dissolution and they found the co-grinding 
technique to significantly increase the dissolution rate of the poorly soluble drug carbamazepine 
(CBZ). However, they did not explore the handling issues which may potentially arise as a result of 
grinding. Given that the grinding process gives rise to charging and that particle triboelectrification 
plays an important role in powder processing,subsequently affecting the quality of formulations 
[16], the objectives of this study were to characterise the full charging profiles of pure CBZ and 
GLU and their co-ground mixtures. As Al-Hamidi et al [2] reported GLU as a new carrier for 
improved dissolution behaviour for poorly soluble drugs, it is important to evaluate its effects on 
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API handling. To the best of our knowledge, there is no work that has looked at the effects of 
duration of grinding on co-ground mixtures of the drug and carrier. 
  
2. Materials and Methods 
2.1. Materials 
Carbamezepine (CBZ) and D-(+)-glucosamine hydrochloride (GLU) were purchased from Sigma-
Aldrich (UK). These materials were used as obtained from the supplier. 
 
2.2. Preparation of physical mixtures of drug-carrier 
Physical mixtures of CBZ: GLU (5 g in total) were prepared by mixing CBZ and GLU in a 
Turbula
TM
 blender (Turbula, Basel, Switzerland) for 10 min. Different weight ratios of drug: carrier 
(1:1, 1:2 and 1:4 w/w) were prepared for comparison purposes. After mixing, the powders were 
stored in a screw-cap glass vial for one week at room temperature before use. 
 
2.3. Preparation of co-ground mixtures of drug-carrier 
Co-grinding of the formulations was conducted according to Al-Hamidi et al., [26, 27]. Briefly, co-
grinding of different ratios of drug to carrier (1:1, 1:2 and 1:4 w/w) was achieved using a ball mill 
(Pulverisette 6, Fritsch, Germany). The total amount of drug: carrier was kept constant for all 
formulations (20 g) during co-grinding process. The volume of the mill chamber was 250 mL. Eight 
stainless steel balls, with diameter 20 mm, were used and occupied one third of the volume of the 
chamber. The vibration rate was 400 rpm. The samples (drug: carrier) were subjected to different 
grinding times (10, 30 and 60 min).  
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2.4. Scanning electron microscopy (SEM) 
Electron micrographs of different samples were obtained using a scanning electron microscope 
(Leica Cambridge S360, UK) operating at 15 kV. The samples were mounted on a metal stub with 
double-sided adhesive tape and coated under vacuum with gold in an argon atmosphere prior to 
observation. Micrographs with different magnifications were recorded to study the morphology of 
the different samples. 
2.5. Particle Size Analysis (PSD) 
Particle size distribution plots of all formulations were conducted using a Sympatec laser diffraction 
particle size analyser (Clausthal-Zellerfeld, Germany). The average particle diameters (D10%, 
D50%, and D90%) were calculated automatically using the software provided. Approximately 2-3 g 
of the sample was transferred into the funnel of the VIBRI (vibrator feeder). The sample container 
was cautiously tapped against the funnel to ensure all of the content was transferred. This was to 
ensure that the material flowed through the vibrating chute into the groove of the rotary table. All 
sample data was analysed using the software provided. 
2.6. Differential scanning calorimetry (DSC) 
Samples of CBZ, GLU and the co-ground formulations (3-6 mg) were placed in standard 
aluminium pans (40 µL) with a vented lid. The crimped aluminium pans were heated from 20 to 
250 ˚C at a scanning rate of 10 °C/min using nitrogen as a purge gas in a DSC 1 (Mettler-Toledo, 
Switzerland). The enthalpy, onset temperatures and melting points of the samples were obtained 
using the software provided. 
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2.7. X-ray powder diffraction (XRPD) 
The pure CBZ, GLU and their co-ground samples were characterised by X-ray powder diffraction 
(XRPD) according to the methodology reported by Laity et al., [28] using a D2 Phaser 
diffractometer (Bruker AXS GmbH, Karlsruhe, Germany), with a sealed microfocus generator 
operated at 30 kV and 10 mA, producing CuKa (λX = 0.1542 nm) radiation and a Lynxeye ‘silicon 
strip’ multi-angle detector. The samples were scanned in Bragg-Brantano geometry, over a 
scattering (Bragg, 2θ) angle range from 5 to 100°, in 0.02° steps at 1.5° min− 1. 
2.8. Fourier transform infrared (FT-IR) 
The pure CBZ, GLU and their co-ground samples were characterised also using FT-IR according to 
the methodology detailed by Asare-Addo et al. [25]. In brief, a 5–10 mg sample of pure CBZ, pure 
GLU, Physical mix of CBZ and GLU, CBZ and GLU ground for either 10 min or 60 min (all at a 
1:1 ratio) were placed on an attenuated total reflection (ATR) plate and analysed using FTIR 
spectroscopy (Nicolet 380 FT-IR spectrometer, ThermoElectron Corporation, USA). All samples 
were analysed by measuring the transmittance of infrared wavelengths of the electromagnetic 
spectrum of the sample in the range of 400–4000 cm−1. 
2.9. Electrostatic properties of physical mixture and solid dispersions 
The charge properties of powders were analysed using a recent novel approach developed in our 
laboratory (Figure 1) and reported in Hussain et al., [17]. The experimental apparatus used to 
investigate the triboelectrification of powders consists of a single non-contact electrostatic inductive 
sensor (probe), a charge amplifier unit, a national instrument (NI) data acquisition equipment and 
personal computer for data recording and processing [17]. The developed method offers distinctive 
advantages such as the determination of charge level and charge polarity across population of 
9 
 
 
 
particles. Electrostatic induction method has been previously used by many researchers to 
investigate charging properties of particulate materials [29-34].  
A similar approach based on induction method to investigate the charge properties of single solid 
particle or droplets are also reported by other authors [29-31].  The properties of other materials 
also reported by other authors based on a contact method (particle-electrode) was adapted 
previously by Masuda and Matsusaka to detect bipolar charge distribution by analysing pulsating 
electrical signals generated in gas-solid pipe flow due to charge transfer from particle to the metal 
pipe wall [29-31]. 
Typical example of processed charge signal obtained as a result of un-grounded GLU particles 
moving through the sensor using vibratory orifice feeder under gravity is shown in Figure 2. The 
direction of each peak shows the polarity of charged particles and amplitude from baseline and 
represents the amount of charge on moving particle. This novel method allows the detection and 
measurement of charge distribution on the charge sign basis in a population of particles. A sample 
of each of pure CBZ, GLU and their co-ground mixtures was fed in the cylindrical sensor with the 
help of the vibratory feeder and conveyed toward the sensor by gravity in a vertical direction. 
Special care was taken by considering the adhesion properties of the particles with the wall of the 
sensor. After each experiment, the inner tube was replaced in order to remove any deposits, 
impurities or surface charge that may have been present on the surface from a previous test. A fresh 
sample was used for each test experiment. Each sample was analysed six times in a humidity and 
temperature controlled laboratory maintained at RH= 50 %, 22 ºC). The positive charge is the sum 
of all positive charges whereas the negative charge is the sum of all negative charges. The net 
charge is the sum of positive and negative charges. The charge–to–mass ratio (CMR or charge 
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density) was defined as the charge (negative charge for N–CMR, positive charge for P–CMR, net 
charge for net–CMR) per unit mass, in nC/g. 
 
3. RESULTS AND DISCUSSION 
3.1. Solid state characterization co-ground samples and physical mixtures 
Figure 3 shows the initial particle sizes of the sample used prior to the grinding process and Figure 
4 shows the SEM images of the starting materials before and after being ground for 10 min. Table 
1, shows the particle sizes of the various ratios ground from 10 to 60 min. These results show a 
dramatic decrease in the average particle diameters (D50%) of pure CBZ after grinding for 10 min, 
and further significant reduction in particle size was induced by further grinding to 30 and 60 min 
(P < 0.05, ANOVA test). This was also the case for GLU and co-ground mixtures. The aggregation 
in Figure 4 suggests that the smaller particles which were generated due to the grinding process are 
inherently more cohesive. It is thought that the surface free energy becomes predominant over the 
effect of gravitation forces when the particles become very fine. The effect of mechanical stress can 
result in an increase in the intensity of free electrons at the particle surface thereby increasing the 
surface free energy of powders dramatically [35]. XRPD showed characteristic diffraction peaks for 
CBZ form III (β-form) at 2θ of 10.5, 12.95 and 15.2 (Figure 5a) [36, 37]. The XRPD pattern of the 
pure CBZ and the ground CBZ displayed similar diffraction patterns. This suggests that CBZ 
particles did not undergo structural modification following grinding for 10 and 60 min (Figure 5a). 
There was however differences in the relative intensities of their peaks and this were attributed to 
the differences in the crystal sizes as a result of the grinding process. Figure 5b also showed a 
significant reduction in the crystallinity of GLU with the grinding time. DSC, however, showed the 
presence of an extra peak present for the CBZ ground for 60 min (indicated by red arrow, Figure 
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6a). This suggested that the long grinding time (60 min) induced some degree of polymorphism in 
the sample (Figure 6a). Pure CBZ displayed a melting peak at 176 ºC, followed by an exothermic 
peak at 179 ºC (an indication of solid-solid transformation of polymorphic form III to I) and then a 
sharp endothermic peak at 192 ºC (melting of form I) [38]. These processes were also evident in the 
ground samples.  Grzesiak et al. [39] conducted an extensive study into the various polymorphic 
forms of CBZ. Their experimentation showed that all CBZ forms were transformed to form I 
(triclinic form) on heating, but this transformation occurred at different temperatures depending on 
the original polymorph. So at a heating rate of 10 ºC/min, CBZ in its trigonal (form II), P-
monoclinic (form III), or C-monoclinic (form IV) exhibited a transformation occuring at 135-170 
ºC, 162-175 ºC, or 178-187 ºC respectively, after which they melted at ~190 ºC [39]. The presence 
of a transition peak at 186 ºC for CBZ ground for 60 min indicates that this sample also contains 
CBZ form IV as a result of the prolonged grinding time. As a result, it can be concluded that the 
CBZ subjected to longer grinding times contained mixtures of forms III and IV. Figure 5c shows a 
reduction in the crystallinity of the samples subjected to the co-grinding process. This was in 
agreement with work done by Al-Hamidi et al. [26]. Figure 6b, shows glucosamine to have a 
melting point of 210 °C, which is also in agreement with Asare-Addo et al., [25]. DSC can also be 
used to reflect miscibility by a shift in the melting endotherm of drug [40-43], as well as identifying 
different polymorphs [44]. Figure 6c shows the distinctive peak for glucosamine as indicated by the 
black arrow as well as the melting peak for CBZ in the PM at 1:1 ratio. The samples co-ground for 
10 and 60 min showed CBZ peaks similar to those in Figure 6a. The glucosamine peaks were also 
present but displayed sharper melting endotherms. This means the co-grinding process did not 
induce any significant changes in the thermal behaviour of CBZ. The absence of any melting point 
depression indicates that CBZ and GLU are immiscible as the chemical potential of CBZ remained 
unchanged in the glucosamine [41]. FT-IR data showed characteristic peaks for CBZ in its 
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unground and ground states (Figure 7). These were found at 3464 cm
−1
 (−NH valence vibration), 
1676 cm
−1
 (–CO–R vibration), 1605 and 1593 cm−1 (range of –C C– and –C O vibrations and –
NH deformation). The FT-IR spectra were synonymous with polymorph III [37] and indicated that 
the grinding was not associated with changes at the molecular level [26].  
3.2 Triboelectrification studies 
Al-Hamidi et al. reported a remarkable improvement in the dissolution of CBZ using GLU as a 
hydrophilic carrier using a co-grinding technique [26]. Despite the improvement in the dissolution 
process, it is known that particle charging can arise due to the grinding process and can cause 
problems in the manufacture of formulations by affecting powder flow, reducing fill and dose 
uniformity [18, 19]. This can also cause adhesion and deposition of particles to walls especially in 
case where the samples have been ground to fine particles [20, 21]. It is therefore important to 
evaluate the charges associated with the grinding process to allow the assessment of formulations 
that are easy to handle during manufacturing as well as improving dissolution. Powders may 
develop different polarities and the magnitude of these charges depends on the intrinsic properties 
of the powders and the types of surfaces the powders have been in contact with during processing. 
In general, fine particulates tend to charge negatively, whereas large particles tend to charge 
positively. Lacks and Levandovsky, 2007 [45] provided a hypothetical mechanism for particle size 
dependent charging. Assuming that the surface density of trapped electrons is initially the same on 
all particles, it has been argued that collisions allow electrons trapped in high-energy states on one 
particle to transfer to the vacant low-energy states on another particle. This has been recently 
discussed in a recent review [46]. The charge density of the pure CBZ drug was higher than that of 
pure GLU carrier (1.7 ± 0.4 versus 0.5 ± 0.2 nC/g) (Figure 8). This agrees with previous studies, 
which showed APIs to exhibit generally higher charge densities in comparison to excipients [16]. 
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Charge distribution analyses showed pure CBZ to have a primarily a positive charge behaviour 
(Figure 9a) whereas pure GLU demonstrated a bipolar charge behaviour (P-CMR and N-CMR of 
1.2 ± 0.5 and -0.7 ± 0.3 nC/g respectively) (Figure 9b). After grinding, both ground CBZ (Figure 
9a) and ground GLU (Figure 9a) showed primarily positive charge behaviours. The net-charge 
density of CBZ and GLU generally increased with increasing grinding time, except for CBZ ground 
for 60 min, which showed a similar charge density to CBZ ground for 10 min (Figure 8). 
Regardless of CBZ:GLU ratio, and in contrast to  CBZ:GLU physical mixtures that showed bipolar 
charge behaviours and overall positive net-charge densities (Figures 9c,d,e), all ground CBZ:GLU 
co-ground mixtures (1:1, 1:2 and 1:4) exhibited primarily electronegative charge behaviours with 
the  highest net-charge density observed for CBZ:GLU ground for 10 min (Figures 9c,d,e). It can be 
assumed that during the grinding process, electrons are being transferred from the stainless steel 
surface to the negatively charged powder particles. The effect of both CBZ:GLU ratio and grinding 
time on the charging properties of ground CBZ:GLU mixtures are shown in Figures 10a and b. It 
can be observed that the net charge density for ground CBZ:GLU mixtures increased (and the 
absolute charge density decreased) with increasing duration of grinding (Figures 10a and b). In 
general, particle charging increases with an increase in the level of energy introduced to the solid 
particles [20]. The net charge density decreased with increasing CBZ content in CBZ:GLU mixtures 
up to 30 %, above which the net charge density increased (Figures 10a and b). 
4. CONCLUSIONS 
Solid states analysis showed polymorphic transformations to occur with the CBZ as a result of the 
grinding process. Solid-state analysis also showed CBZ and GLU to be crystalline despite increased 
grinding time. The charge density of the pure CBZ drug was higher than that of pure GLU carrier 
and showed glucosamine to have a very low charge. As various strategies including co-grinding are 
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used in the improvement of the solubility of drugs with poor aqueous solubility, it is important to 
characterize and predict the electrostatic behaviour of such mixtures before and after processing. 
The results showed the net charge density of the samples to decrease with increasing CBZ content 
in CBZ:GLU mixtures up to 30 %, above which the net charge density increases. The novel 
technique reported here for determining the charge of the dispersions could therefore also be used 
as tool to help a formulator determine the appropriate formulations that enhance dissolution but also 
improve handling.  
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Tables 
Table 1. Particle size analysis of pure carbamazepine, glucosamine and their co-ground mixtures 
Formulation 
Grinding time 
(min) D10% (µm) D50% (µm) D90% (µm) 
CBZ  10 1.52 31.55 272.55 
GLU  10 0.85 5.20 120.60 
CG 1:1  10 1.75 27.91 239.42 
GG 1:2  10 1.57 17.61 143.34 
CG 1:4  10 1.41 20.86 280.02 
CBZ  30 1.48 24.48 276.55 
GLU  30 1.15 13.30 132.90 
CG 1:1  30 2.13 31.35 236.85 
GG 1:2  30 2.20 27.85 192.38 
CG 1:4  30 1.56 28.51 279.18 
CBZ  60 1.37 15.87 261.61 
GLU  60 1.11 9.80 113.04 
CG 1:1  60 2.21 28.42 203.15 
GG 1:2  60 1.80 22.82 208.28 
CG 1:4  60 2.65 36.10 282.44 
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Figure Titles 
Figure 1. Schematic of experimental setup used in the determination of the formulations charge.  
Figure 2. Particle size analysis of a) pure CBZ, GLU and physical mixes of carbamazepine (CBZ) 
and glucosamine 
Figure 3. SEM images a) CBZ b) CBZ 60 min ground c) GLU d) GLU 60 min ground e) PM CBZ-
GLU f) ratio 1:1 60 min ground 
Figure 4. XRD pattern of a) pure CBZ and CBZ ground for 10 and 60 min, b) pure GLU and GLU 
ground for 10 and 60 min, c) CBZ:GLU 1:1 physical mix ratio and same ratio ground for 10 and 60 
min. 
Figure 5. DSC plot of a) pure CBZ and CBZ ground for 10 and 60 min, b) pure GLU and GLU 
ground for 10 and 60 min, c) CBZ:GLU 1:1 physical mix ratio and same ratio ground for 10 and 60 
min. 
Figure 6. FT-IR spectrum of a) pure CBZ, b) pure GLU, c) GLU ground for 10, d) GLU ground for 
60 min, e) CBZ:GLU 1:1 physical mix, f) CBZ:GLU 1:1 co-ground for 10 min, g) CBZ:GLU 1:1 
co-ground for 60 min,  h) CBZ ground for 10 and i) CBZ ground for 60 min. 
Figure 7. Net- charge to mass ratio (net-CMR) for pure carbamazepine (CBZ), pure glucosamine 
HCl (GLU) and physical mixtures of CBZ:GLU at different ratios (1:1, 1:2 and 1:4, w:w) ground 
for different times (10, 30 and 60 min). 
Figure 8. Positive-charge to mass ratio (P-CMR) and negative-charge to mass ratio (N-CMR) for 
pure carbamazepine (CBZ) (a), pure glucosamine HCl (GLU) (b) and physical mixtures of 
CBZ:GLU at 1:1 (c), 1:2 (d) and 1:4 (e) ratios (w:w) ground for different times (10, 30 and 60 min). 
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Figure 9. Surface plot (a) and contour plot (b) of net-CMR in relation to % CBZ in CBZ:GLU 
mixture and grinding times (min). 
 
Figures 
 
Figure 1. 
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Figure 4. 
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